HLA-C and neoplasm: Recognition of cancer cells by immune cells mainly relies on presentation of tumor-specific antigens by the major histocompatibility complex (MHC) molecules on the surface of cancer cells which prime and activate the immune cells that can ultimately trigger cancer cell death (Schreiber et al., 2011).